Yilmaz Transport Ulus.nak.petrol Pharmaceutical Import Profile — Turkey (DGFT 2022–2026)

Name: Yilmaz Transport Ulus.nak.petrol Pharmaceutical Import Records from India — 4 Products, $955.3K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Yilmaz Transport Ulus.nak.petrol — Pharmaceutical Importer Profile (2026) | 4 Products, $955.3K Trade | TransData Nexus

Yilmaz Transport Ulus.nak.petrol

Pharmaceutical Importer · Turkey · Advanced Antibiotics Focus · $955.3K Total Trade · DGFT Verified

Yilmaz Transport Ulus.nak.petrol is a pharmaceutical importer based in Turkey with a total trade value of $955.3K across 4 products in 3 therapeutic categories. Based on 29 verified import shipments from Indian Customs (DGFT) records, Yilmaz Transport Ulus.nak.petrol is the #1 buyer in 2 products including Levofloxacin, Sitagliptin. Yilmaz Transport Ulus.nak.petrol sources from 5 verified Indian suppliers, with Laborate Pharmaceuticals India Limited accounting for 47.3% of imports.

Yilmaz Transport Ulus.nak.petrol — Import Portfolio & Supplier Network

Yilmaz Transport Ulus.nak.petrol import network — 4 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Yilmaz Transport Ulus.nak.petrol?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Laborate Pharmaceuticals India Limited	$1.2M	168	47.3%
Zypher Lifesciences Private Limited	$898.4K	30	35.1%
Medcell Pharma

What Formulations Does Yilmaz Transport Ulus.nak.petrol Import?

Formulation	Value	Ships
Sitarux-m (sitagliptin phosphate &	$128.4K	3
Levorux (levofloxacin infusion	$122.1K	3
Tamrux-d (tamsulosin hydrochloride	$109.5K	3
Pararux (paracetamol 1g/100ML solution	$104.5K	3
Flucorux (flucoconazole capsules BP	$103.8K	3
Pararux (paracetamol infusion 1g/100ML	$50.0K	1
Ruxime (cefixime capsules) Each hard	$50.0K	1
Ruxacin (amikacin sulphate injection	$50.0K	1
1-299 audimox-500 capsule (alu-alu)	$50.0K	1
1-496 audimox-500 capsule alu-aluamoxicillin trihydrate 500mgbatchnos:ndice-005 manufacturing . 05/23 exp. 04/26	$50.0K	1
Clanoxy 1000 MG tablets 1 x 10t amoxicillin & clavulanate potassium tablet USP 1000 MG	$50.0K	1
Clanoxy 625MG tablet 1 x 10t amoxicillin & clavulanate potassium TAB. USP 625MG	$50.0K	1
1-299 audimox-500 capsule alu-aluamoxicillin trihydrate 500mgbatchnos:ndice-010 to ndice-012 manufacturing . 10/23 exp.	$50.0K	1
1-290 audimox-500 capsule (alu-alu)(amoxicillin trihydrate 500MG)batchnos:ndice-016 & ndice-018 mfg. 12/23 exp. 11/26	$50.0K	1
1-296 audimox-500 capsule (alu-alu)(amoxicillin trihydrate 500MG)batchnos:odice-001 & odice-002 mfg. 01/24 exp. 12/26	$50.0K	1

Yilmaz Transport Ulus.nak.petrol imports 116 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 4 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Ofloxacin	Advanced Antibiotics	$450.0K	9	0.2%	12
2	Amikacin	Advanced Antibiotics	$205.3K	14	1.0%	13
3	Levofloxacin	Antibiotics	$150.0K	3	0.2%	1
4	Sitagliptin	Diabetes & Endocrine	$150.0K	3	0.2%	1

Yilmaz Transport Ulus.nak.petrol imports 4 pharmaceutical products across 3 categories into Turkey totaling $955.3K. The company is the #1 buyer for 2 products: Levofloxacin, Sitagliptin.

Yilmaz Transport Ulus.nak.petrol — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Yilmaz Transport Ulus.nak.petrol is a pharmaceutical importer and buyer based in Turkey, specializing in the acquisition of finished pharmaceutical formulations from international suppliers. The company plays a pivotal role in Turkey's pharmaceutical distribution network, ensuring the availability of essential medications across the nation. While specific details about its headquarters and parent company are not publicly disclosed, Yilmaz Transport Ulus.nak.petrol's operations are integral to the Turkish healthcare system, facilitating the importation and distribution of a diverse range of pharmaceutical products.

2Distribution Network

Yilmaz Transport Ulus.nak.petrol's distribution network encompasses multiple warehouse locations strategically situated to optimize logistics and ensure timely delivery of pharmaceutical products throughout Turkey. The company's logistics capabilities are robust, enabling efficient handling and storage of a wide array of pharmaceutical formulations. While specific geographic coverage details are not publicly available, the company's extensive import activities suggest a comprehensive reach within Turkey and potentially to neighboring regions.

3Industry Role

In Turkey's pharmaceutical supply chain, Yilmaz Transport Ulus.nak.petrol functions primarily as a pharmaceutical importer and distributor. The company is responsible for sourcing finished pharmaceutical formulations from international suppliers and ensuring their availability in the Turkish market. This role is crucial for maintaining a steady supply of medications, particularly those not produced domestically, thereby supporting the healthcare needs of the Turkish population.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Yilmaz Transport Ulus.nak.petrol

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Yilmaz Transport Ulus.nak.petrol's sourcing strategy exhibits a high degree of concentration, with a significant portion of its imports originating from a select group of Indian suppliers. The top five suppliers account for approximately 99% of the total import value, indicating a strategic choice to establish strong partnerships with these suppliers. This concentrated sourcing approach may offer benefits such as favorable pricing and consistent product quality. However, it also introduces potential risks, including supply chain disruptions if any of these key suppliers encounter operational challenges. The company's reliance on a limited number of suppliers underscores the importance of maintaining stable and reliable relationships to mitigate such risks.

2Supply Chain Resilience

The resilience of Yilmaz Transport Ulus.nak.petrol's supply chain is closely tied to the stability and reliability of its Indian suppliers. The company's import portfolio comprises 116 unique pharmaceutical formulations, suggesting a diverse range of products sourced from its suppliers. While this diversity may provide some buffer against supply chain disruptions, the heavy reliance on a few key suppliers could pose challenges if any face operational or regulatory issues. To enhance supply chain resilience, it would be prudent for Yilmaz Transport Ulus.nak.petrol to consider diversifying its supplier base and establishing contingency plans to address potential disruptions.

Importing Pharmaceuticals into Turkey — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Turkey

1Regulatory Authority & Framework

In Turkey, the pharmaceutical sector is regulated by the Turkish Medicines and Medical Devices Agency (TİTCK), operating under the Ministry of Health. The primary legislation governing pharmaceutical imports is the Pharmaceutical and Medical Preparations Law No. 1262, which outlines the requirements for importing, exporting, and manufacturing pharmaceutical products. According to this law, obtaining market authorization from the Ministry of Health is mandatory before importing pharmaceutical products into Turkey. This authorization ensures that imported products meet the necessary standards for safety, efficacy, and quality.

2Import Licensing & GMP

To import pharmaceutical products into Turkey, companies must obtain an import license from the Ministry of Health. This process involves submitting a comprehensive application that includes product documentation, clinical trial data, quality certificates, and a pharmacovigilance plan. Additionally, an Import Compliance Certificate is issued once the license is obtained, facilitating the import process. The Turkish regulatory framework recognizes Good Manufacturing Practice (GMP) certifications from reputable international bodies, such as the European Union (EU) GMP, World Health Organization (WHO) GMP, and Pharmaceutical Inspection Co-operation Scheme (PIC/S). These certifications are essential for ensuring that imported pharmaceutical products adhere to high manufacturing standards.

Yilmaz Transport Ulus.nak.petrol — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Yilmaz Transport Ulus.nak.petrol's product strategy focuses on importing pharmaceutical formulations in the therapeutic areas of advanced antibiotics and diabetes & endocrine treatments. The company's top five imported products include Ofloxacin, Amikacin, Levofloxacin, and Sitagliptin, which are essential in treating various infections and managing diabetes. The demand for these products in Turkey is driven by the prevalence of bacterial infections and the increasing incidence of diabetes, necessitating a reliable supply of these medications to meet public health needs.

2Sourcing Profile

Yilmaz Transport Ulus.nak.petrol's sourcing strategy is centered on acquiring generic pharmaceutical formulations from international suppliers, particularly from India. The company imports a diverse range of 116 unique formulations, indicating a broad approach to procurement. India's well-established pharmaceutical manufacturing sector, known for producing high-quality generic medications, aligns with Yilmaz Transport Ulus.nak.petrol's objective of providing cost-effective and reliable pharmaceutical products to the Turkish market.

3Market Positioning

Seller's Guide — How to Become a Supplier to Yilmaz Transport Ulus.nak.petrol

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to collaborate with Yilmaz Transport Ulus.nak.petrol, given the company's extensive import activities and reliance on Indian pharmaceutical products. Potential gaps in Yilmaz Transport Ulus.nak.petrol's current sourcing include the need for additional suppliers to mitigate risks associated with supply chain disruptions and to diversify its product offerings. New suppliers can explore these opportunities by offering high-quality products, competitive pricing, and reliable supply chains to meet the company's requirements.

2Requirements & Qualifications

Indian exporters aiming to supply Yilmaz Transport Ulus.nak.petrol and the Turkish market must adhere to Turkey's regulatory standards. This includes obtaining market authorization from the Ministry of Health, ensuring compliance with Good Manufacturing Practice (GMP) standards recognized by the EU, WHO, or PIC/S, and meeting labeling and packaging requirements in Turkish. Additionally, exporters must provide necessary documentation, such as certificates of analysis and health certificates, to facilitate the import process.

3How to Approach

Frequently Asked Questions — Yilmaz Transport Ulus.nak.petrol

What products does Yilmaz Transport Ulus.nak.petrol import from India?

Yilmaz Transport Ulus.nak.petrol imports 4 pharmaceutical products across 3 categories. Top imports: Ofloxacin ($450.0K), Amikacin ($205.3K), Levofloxacin ($150.0K), Sitagliptin ($150.0K).

Who supplies pharmaceuticals to Yilmaz Transport Ulus.nak.petrol from India?

Yilmaz Transport Ulus.nak.petrol sources from 5 verified Indian suppliers. The primary supplier is Laborate Pharmaceuticals India Limited (47.3% of imports, $1.2M).

What is Yilmaz Transport Ulus.nak.petrol's total pharmaceutical import value?

Yilmaz Transport Ulus.nak.petrol's total pharmaceutical import value from India is $955.3K, based on 29 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Yilmaz Transport Ulus.nak.petrol focus on?

Yilmaz Transport Ulus.nak.petrol imports across 3 categories. The largest: Advanced Antibiotics (68.6%), Antibiotics (15.7%), Diabetes & Endocrine (15.7%).

Get Full Yilmaz Transport Ulus.nak.petrol Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.